01 1Cenexi - Laboratoires Thissen Sa
01 1omacetaxine mepesuccinate
01 1Belgium
NDC Package Code : 69605-732
Start Marketing Date : 2012-11-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (3.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
A OMACETAXINE MEPESUCCINATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of OMACETAXINE MEPESUCCINATE, including repackagers and relabelers. The FDA regulates OMACETAXINE MEPESUCCINATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. OMACETAXINE MEPESUCCINATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A OMACETAXINE MEPESUCCINATE supplier is an individual or a company that provides OMACETAXINE MEPESUCCINATE active pharmaceutical ingredient (API) or OMACETAXINE MEPESUCCINATE finished formulations upon request. The OMACETAXINE MEPESUCCINATE suppliers may include OMACETAXINE MEPESUCCINATE API manufacturers, exporters, distributors and traders.
click here to find a list of OMACETAXINE MEPESUCCINATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing OMACETAXINE MEPESUCCINATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for OMACETAXINE MEPESUCCINATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture OMACETAXINE MEPESUCCINATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain OMACETAXINE MEPESUCCINATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a OMACETAXINE MEPESUCCINATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of OMACETAXINE MEPESUCCINATE suppliers with NDC on PharmaCompass.
We have 1 companies offering OMACETAXINE MEPESUCCINATE
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
